Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Establish Best Treatment Strategy for T4 Esophageal Cancer

NCT06531434 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.

NCT NCT06531434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06531434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Establish Best Treatment Strategy for T4 Esophageal Cancer
Lead sponsor
National Cheng-Kung University Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 1, 2024
Completion date
April 30, 2026
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer tnm staging primary tumor (t) t4